Overload

MicroStrategy Celebrates Customer and Partner Awards and the Launch of Auto Express at its 27th MicroStrategy World

Retrieved on: 
星期四, 五月 9, 2024
Data Management, Technology, Professional Services, Web3, Digital Cash Management, Digital Assets, Other Technology, Software, Artificial Intelligence, Cryptocurrency, Fintech, Finance, Bitcoin, Organization, Bayer, MicroStrategy, EVP, Research, Waldorf Astoria New York, Partnership, Auto Express, Citibank, Overload, Microsoft, Bitwise operation, Wuori, United, Corporation, AWS

For photos of the awards presentation and more information about each award, read MicroStrategy’s post, Cheers to our 2024 Customer Award Winners .

Key Points: 
  • For photos of the awards presentation and more information about each award, read MicroStrategy’s post, Cheers to our 2024 Customer Award Winners .
  • Phong Le, President and CEO of MicroStrategy, gave the World 2024 keynote, which is also now available for streaming .
  • The keynote included strategic partners AWS and Microsoft, plus a customer panel joined by Bayer Pharmaceuticals, the U.S. Department of State, and Vuori.
  • “World 2024 was an enormous success,” said Carla Fitzgerald, EVP and Chief Marketing Officer at MicroStrategy.

New Survey by Visual One Intelligence Shows IT Teams Prioritizing Less VMware, More Cloud Efficiency

Retrieved on: 
星期三, 五月 8, 2024
VMware, Organization, Overload, Software as a service, Forecasting, Job satisfaction, Retail

DALLAS, May 8, 2024 /PRNewswire/ -- A new survey shows that IT infrastructure teams' top priorities today are directly focused on reducing VMware dependency while moving on-prem workloads to the cloud – with greater cost efficiency than in the past.

Key Points: 
  • DALLAS, May 8, 2024 /PRNewswire/ -- A new survey shows that IT infrastructure teams' top priorities today are directly focused on reducing VMware dependency while moving on-prem workloads to the cloud – with greater cost efficiency than in the past.
  • Traditionally prioritized goals such as reducing downtime and, consolidating tools remained important but ranked lower on teams' list of priorities.
  • "There is a growing focus on the 'big fish' of cost savings," said Phil Godwin, President & COO of Visual One Intelligence™.
  • Visual One Intelligence™ – a SaaS solution specializing in hybrid infrastructure monitoring, forecasting, and optimization – conducted the third-party survey in December 2023.

Datadog Launches IT Event Management to Enhance AIOps Capabilities

Retrieved on: 
星期一, 五月 6, 2024
Unify, Organization, AI, Triage, Confusion, Attention, Overload, Noise, Fatigue, Correlation, Event management, Database, Infrastructure, Incident management, Risk management

NEW YORK, May 6, 2024 /PRNewswire/ -- Datadog, Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications, today announced the general availability of IT Event Management to its suite of AIOps capabilities. With Event Management, Datadog intelligently consolidates, correlates and enriches all alert events and important signals from Datadog and existing third-party observability tools into one consistent view. This process reduces alert fatigue so teams can focus their time and resources on remediating issues.

Key Points: 
  • NEW YORK, May 6, 2024 /PRNewswire/ -- Datadog , Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications, today announced the general availability of IT Event Management to its suite of AIOps capabilities.
  • With Event Management, Datadog intelligently consolidates, correlates and enriches all alert events and important signals from Datadog and existing third-party observability tools into one consistent view.
  • Datadog's AIOps capabilities enable teams to proactively identify underlying causes, reduce noise with intelligent event correlation and take action sooner.
  • With the addition of Event Management, Datadog's AIOps capabilities help organizations to:
    Unify Alert Data: Aggregate alerts and change events from third-party tools and Datadog into one case view to break down tool sprawl and simplify investigations.

Amagi's Latest FAST Report Unveils the Rise of a Diverse Global FAST Marketplace Emerging From U.S. Roots

Retrieved on: 
星期二, 四月 30, 2024
Media, AccuWeather, Ecosystem, AVOD, BeIN Sports, News, Sport, Business operations, Research, LATAM, Growth, Software as a service, Habit, CTV Life Channel, CTV, Entrepreneurship, SVOD, SVP, Overload, PAC-12, Music, Strategy, NBCUniversal, MAU, Advertising, The Roku Channel, Paradox, Video game

"The 11th edition of the Amagi Global FAST report provides valuable insights into content preferences and viewing habits across diverse regions," said FASTMaster Gavin Bridge, VP of Media Research at CRG Global.

Key Points: 
  • "The 11th edition of the Amagi Global FAST report provides valuable insights into content preferences and viewing habits across diverse regions," said FASTMaster Gavin Bridge, VP of Media Research at CRG Global.
  • The newly released Amagi Global FAST Report offers critical data and insights derived from more than 50 FAST services and 5,000+ channels using Amagi THUNDERSTORM, the company's cutting-edge server-side ad insertion (SSAI) platform.
  • Key takeaways from the Amagi Global FAST Report include:
    Continued Growth in FAST Viewership: The report identifies a robust increase in FAST viewership, with a double-digit growth in monthly active users (MAU) across all of Amagi's FAST platforms (ranging from 25-75% YoY).
  • "The 11th edition of the Amagi Global FAST Report provides unmatched data and analysis on this burgeoning FAST ecosystem," said Srinivasan KA, Co-Founder and Chief Revenue Officer of Amagi.

Amagi's Latest FAST Report Unveils the Rise of a Diverse Global FAST Marketplace Emerging From U.S. Roots

Retrieved on: 
星期二, 四月 30, 2024
Media, AccuWeather, Ecosystem, AVOD, BeIN Sports, News, Sport, Business operations, Research, LATAM, Growth, Software as a service, Habit, CTV Life Channel, CTV, Entrepreneurship, SVOD, SVP, Overload, PAC-12, Music, Strategy, NBCUniversal, MAU, Advertising, The Roku Channel, Paradox, Video game

"The 11th edition of the Amagi Global FAST report provides valuable insights into content preferences and viewing habits across diverse regions," said FASTMaster Gavin Bridge, VP of Media Research at CRG Global.

Key Points: 
  • "The 11th edition of the Amagi Global FAST report provides valuable insights into content preferences and viewing habits across diverse regions," said FASTMaster Gavin Bridge, VP of Media Research at CRG Global.
  • The newly released Amagi Global FAST Report offers critical data and insights derived from more than 50 FAST services and 5,000+ channels using Amagi THUNDERSTORM, the company's cutting-edge server-side ad insertion (SSAI) platform.
  • Key takeaways from the Amagi Global FAST Report include:
    Continued Growth in FAST Viewership: The report identifies a robust increase in FAST viewership, with a double-digit growth in monthly active users (MAU) across all of Amagi's FAST platforms (ranging from 25-75% YoY).
  • "The 11th edition of the Amagi Global FAST Report provides unmatched data and analysis on this burgeoning FAST ecosystem," said Srinivasan KA, Co-Founder and Chief Revenue Officer of Amagi.

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024

Retrieved on: 
星期二, 四月 23, 2024
Annual, Cancer, International, Partner, Liver disease, EUR, Brussels Stock Exchange, Convertible, European, Overload, Transaction, Committee, Annual report, Heart failure, Security (finance)

Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.

Key Points: 
  • Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.
  • The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .
  • The Annual and Extraordinary General Meetings of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CET.
  • The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual and Extraordinary General Meetings of Shareholders.

Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024

Retrieved on: 
星期二, 四月 23, 2024
Annual, Cancer, International, Partner, Liver disease, EUR, Brussels Stock Exchange, Convertible, European, Overload, Transaction, Committee, Annual report, Heart failure, Security (finance)

Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.

Key Points: 
  • Ghent, Belgium – 23 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual and Extraordinary General Meetings of Shareholders on Thursday, 23 May 2024.
  • The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .
  • The Annual and Extraordinary General Meetings of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CET.
  • The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual and Extraordinary General Meetings of Shareholders.

Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023

Retrieved on: 
星期二, 四月 23, 2024
Annual, Cancer, International, Partner, Liver disease, EUR, Brussels Stock Exchange, Convertible, European, Overload, Transaction, Committee, Annual report, Heart failure, Security (finance)

The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .

Key Points: 
  • The annual report for the financial year 2023 has been published on Sequana Medical's website and can be accessed here .
  • The Annual and Extraordinary General Meetings of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CET.
  • The full convening notice with the agenda and proposed resolutions can be accessed on the Sequana Medical website: www.sequanamedical.com/investors/shareholder-information .
  • The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual and Extraordinary General Meetings of Shareholders.

Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality

Retrieved on: 
星期四, 五月 2, 2024
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, GV, Harvard University, Cancer, Genetics, Cell, Broad Institute, Survival, GV (company), Drug resistance, Growth, Overload, Oncogene, Patient, Neoplasm, NIBR, Investment, MIT, Pharmaceutical industry

Delphia Therapeutics, Inc. (Delphia), announced its launch today to pioneer a new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation.

Key Points: 
  • Delphia Therapeutics, Inc. (Delphia), announced its launch today to pioneer a new area of cancer biology – activation lethality – which targets cancer's surprising vulnerability to oncogene overactivation.
  • “Our activation lethality platform offers the potential for new cancer medicines that are effective on their own while also combating the emergence of resistance to classic targeted therapies.
  • Delphia integrates tumor genetics, novel functional genomic approaches, and studies of inhibitor drug resistance to identify targets that drive activation lethality.
  • Through its activation lethality platform, Delphia is advancing a pipeline of first-in-class cancer medicines that aim to better control oncogenic pathways.

Axe and Driveline Baseball Unveil Power Trainer: Designed to Unlock Hitter Potential

Retrieved on: 
星期四, 四月 11, 2024
Mechanics, Axe, Partnership, Power, Engineering, Overload, Koko (gorilla), GM, MOI, Athlete, Knowledge, Sports equipment

KENT, Wash., April 11, 2024 /PRNewswire/ -- Baseball training innovators Axe and Driveline Baseball have joined forces again to launch the Power Trainer.

Key Points: 
  • KENT, Wash., April 11, 2024 /PRNewswire/ -- Baseball training innovators Axe and Driveline Baseball have joined forces again to launch the Power Trainer.
  • Building on the success of their acclaimed Axe Speed Trainers, the Power Trainer represents another step forward in their collaborative effort.
  • The Power Trainer combines Axe's bat design and engineering expertise with Driveline Baseball's cutting-edge data and hitting knowledge.
  • "We are thrilled to partner again with Driveline Baseball to create a training bat unlike any other," says Jay Helmick, GM of Axe Bat.